CHANGES IN ANTITHROMBIN INDICATORS IN ATRIAL FIBRILLATION

AKHMEDOVA Nilufar Sharipovna, RIZAYEVA Malika Jamolovna

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2024-yil

Annotatsiya

Atrial fibrillation (AF) is a very common heart rhythm disorder, which represents a pressing problem in modern arrhythmology. The incidence of AF has increased by 13% over the past 20 years. AF is associated with a high incidence of adverse outcomes, the main ones being thromboembolic complications, the onset of chronic heart failure and other adverse outcomes. Currently, the cause of the formation of blood clots, with the support of anticoagulants, in the cavities of the heart is not reliably known.

Maqola ma’lumotlari
MualliflarAKHMEDOVA Nilufar Sharipovna, RIZAYEVA Malika Jamolovna
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2024-06-03
Jild9
Son2
TilRus

Kalit so‘zlar

Ишемическая болезнь сердца, фибрилляция предсердий, тромбоэмболия, антитромбин, осложнения, Coronary heart disease, atrial fibrillation, thromboembolism, antithrombin, complications, yurak ishemik kasalligi, bo`lmacha fibrilatsiya, tromboemboliya, antitrombin, asoratlar

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar